1-7 of 7
Marielle Fournel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 930: Preclinical characterization of MG516, a novel inhibitor of receptor tyrosine kinases involved in resistance to targeted therapies.

Normand Beaulieu, Helene Sainte-Croix, Claire Bonfils, Michael Mannion, Stephane Raeppel, Lubo Isakovic, Stephen Claridge, Oscar Saavedra, Franck Raeppel, Arkadii Vaisburg, James Wang, Marielle Fournel, Jeffrey M. Besterman, Christiane R. Maroun
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 930.
https://doi.org/10.1158/1538-7445.AM2013-930
Published: 15 April 2013
View article titled, Abstract 930: Preclinical characterization of MG516, a novel inhibitor of receptor tyrosine kinases involved in resistance to targeted therapies.
Journal Articles

Abstract 1790: The combination of MGCD265, a Met/VEGFR inhibitor in clinical development, and erlotinib potently inhibits tumor growth by altering multiple pathways including glycolysis

Claire Bonfils, Normand Beaulieu, Marielle Fournel, Helene Ste-Croix, Jeffrey M. Besterman, Christiane R. Maroun
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1790.
https://doi.org/10.1158/1538-7445.AM2012-1790
Published: 15 April 2012
View article titled, Abstract 1790: The combination of MGCD265, a Met/VEGFR inhibitor in clinical development, and erlotinib potently inhibits tumor growth by altering multiple pathways including glycolysis
Journal Articles

Abstract 3610: Potent preclinical anti-tumor activity of MGCD265, an oral Met/VEGFR multitargeted kinase inhibitor in clinical development, in combination with taxanes

Christiane R. Maroun, Helene Ste-Croix, Normand Beaulieu, Claire Bonfils, Marielle Fournel, Isabelle Dupont, Christian Lemoyne, James Wand, Jeffrey M. Besterman
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 3610.
https://doi.org/10.1158/1538-7445.AM2011-3610
Published: 15 April 2011
View article titled, Abstract 3610: Potent preclinical anti-tumor activity of MGCD265, an oral Met/VEGFR multitargeted kinase inhibitor in clinical development, in combination with taxanes
Journal Articles

Abstract 3612: Potent preclinical anti-tumor activity of MGCD265, an orally active Met/VEGFR multitargeted kinase inhibitor in Phase II clinical development, in combination with an EGFR inhibitor

Marielle Fournel, Isabelle Dupont, Claire Bonfils, Marja Dubay, Hélène Ste-Croix, Carole Beaulieu, Normand Beaulieu, Christian Lemoyne, James Wang, Lubo Isakovic, Stephen Claridge, Oscar Saavedra, Franck Raeppel, Stephane Raeppel, Michael Mannion, Arkadii Vaisburg, Robert E. Martell, Jeffrey M. Besterman, Christiane R. Maroun
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3612.
https://doi.org/10.1158/1538-7445.AM10-3612
Published: 15 April 2010
View article titled, Abstract 3612: Potent preclinical anti-tumor activity of MGCD265, an orally active Met/VEGFR multitargeted kinase inhibitor in Phase II clinical development, in combination with an EGFR inhibitor
Journal Articles

Induction of metallothionein-3 transcription as a pharmacodynamic biomarker for histone deacetylase inhibitor MGCD0103 in vitro and in vivo

Jianhong Liu, Claire Bonfils, Marie-Claude Trachy-Bourget, Ann Kalita, Marja Dubay, Yu Hou, Marielle Fournel, Tracy-Ann Patterson, Gregory Reid, Robert Martell, Jeffrey Besterman, Zuomei Li
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 1832.
Published: 01 May 2007
View article titled, Induction of metallothionein-3 transcription as a pharmacodynamic biomarker for histone deacetylase inhibitor MGCD0103 <em>in vitro</em> and <em>in vivo</em>
Journal Articles

Enhanced Isotype-Selectivity and Antiproliferative Activity of Thiophenyl Derivatives of Benzamide HDAC Inhibitors In Human Cancer Cells

Marielle Fournel, Oscar Moradei, Isabelle Paquin, Claire Bonfils, Marie-Claude Trachy-Bourget, Jianhong Liu, T. Pu Yan, Ai-Hua Lu, Julie Pare, Sylvain Lefebvre, Gabi Rahil, A. Robert Macleod, Arkadii Vaisburg, Jeffrey M. Besterman, Zuomei Li
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1110.
Published: 15 April 2006
View article titled, Enhanced Isotype-Selectivity and Antiproliferative Activity of Thiophenyl Derivatives of Benzamide HDAC Inhibitors In Human Cancer Cells
Journal Articles

Sulfonamide Anilides, a Novel Class of Histone Deacetylase Inhibitors, Are Antiproliferative against Human Tumors

Marielle Fournel, Marie-Claude Trachy-Bourget, P. Theresa Yan, Ann Kalita, Claire Bonfils, Carole Beaulieu, Sylvie Frechette, Silvana Leit, Elie Abou-Khalil, Soon-Hyung Woo, Daniel Delorme, A. Robert MacLeod, Jeffrey M. Besterman, Zuomei Li
Journal: Cancer Research
Cancer Res (2002) 62 (15): 4325–4330.
Published: 01 August 2002
View article titled, Sulfonamide Anilides, a Novel Class of Histone Deacetylase Inhibitors, Are Antiproliferative against Human Tumors
Open the PDF for Sulfonamide Anilides, a Novel Class of Histone Deacetylase Inhibitors, Are Antiproliferative against Human Tumors in another window